Next-Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application

List of Tables

The next-generation sequencing market is expected to reach USD 29.53 billion in 2030, up from USD 14.94 billion in 2025, at a CAGR of 14.6% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Product Type, Technology, Workflow, Service, Application
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The growing application of NGS in oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is the primary driver of market expansion. Meanwhile, advanced bioinformatics tools for data analysis and interpretation are facilitating the use of NGS, thereby helping a wider user base adopt the technique.

Next-Generation Sequencing Market - IMG1

"Consumables accounted for the largest share of the product segment in the NGS market in 2024."

The NGS products market is segmented into consumables, platforms, and bioinformatics tools. In 2024, consumables held the largest share. This segment includes reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are used in high volumes across many applications. Demand remains robust because consumables are purchased repeatedly, unlike instruments, which are generally one-time investments. The growing use of targeted sequencing and custom panels is also driving demand for specialized, application-specific consumables. Furthermore, an expanding user base and ongoing improvements in sequencing chemistries are drawing more customers toward consumables to simplify their workflows and improve data quality.

"The academic & research institutes segment accounted for the largest share by services end-user segment in the next-generation sequencing market in 2024."

The next-generation sequencing services market is segmented by end user into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other users. In 2024, academic and research institutes held the largest share. This leadership is supported by strong government and private funding for research programs, enabling higher spending on NGS-related needs, including instruments and consumables. Pharmaceutical and biotechnology companies represented the second-largest end-user segment in the market.

"The Asia Pacific region will grow at the highest CAGR from 2025 to 2030."

The Asia Pacific region is estimated to be the fastest-growing segment of the market, owing to large-scale population genomics projects and rising demand for precision medicines. Additionally, the rising prevalence of rare and genetic diseases is attributed to the aging populations in countries such as Japan and China. These factors are supporting the adoption of sequencing technologies in healthcare management and treatment, driving market growth.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (US)
Revvity (US)
Eurofins Scientific (Luxembourg)
PacBio (US)
Oxford Nanopore Technologies plc. (UK)
Takara Bio Inc. (Japan)
BGI Group (China)
Merck KGaA (Germany)
BD (US)
10X Genomics (US)
New England Biolabs (US)
Promega Corporation (US)
Novogene Co., Ltd. (China)
LGC Limited (UK)
WuXi Biologics (China)
MGI Tech Co. Ltd. (China)
Tecan Trading AG (Switzerland)
Twist Biosciences (US)
Azenta US, Inc. (US)
GenScript (US)
SD Biosensor, Inc. (South Korea)
Fulgent Genetics (US)
Hamilton Company (US)
Zymo Research Corporation (US)
NeoGenomics Laboratories (US)
Psomagen (US)

Research Coverage:

The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the NGS market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product and service portfolio, key strategies such as product and service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is also covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following points:

Analysis of key drivers (advancements in sequencing platforms, rising clinical applications of sequencing, growing demand for precision medicine, declining sequencing costs), restraints (complex data analysis, high initial capital investment), opportunities (integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (standardization issues) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products/services of the next-generation sequencing market
Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the next-generation sequencing market
Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US)

Product Code: BT 2697

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN NEXT-GENERATION SEQUENCING MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 NEXT-GENERATION SEQUENCING MARKET OVERVIEW
3.2 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY OFFERING AND COUNTRY
3.3 NEXT-GENERATION SEQUENCING MARKET, BY COUNTRY
3.4 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING, 2026 VS. 2031 (%)

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Advancements in sequencing platforms
  - 4.2.1.2 Rising clinical applications of sequencing
  - 4.2.1.3 Growing demand for precision medicine
  - 4.2.1.4 Declining costs of sequencing
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Data analysis complexity
  - 4.2.2.2 High capital investments and expenses
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Integration of AI and ML
  - 4.2.3.2 Adoption of long-read sequencing technologies
  - 4.2.3.3 Emphasis on multiomics integration
- 4.2.4 CHALLENGES
  - 4.2.4.1 Standardization issues
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVIES BY TIER 1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT FROM SUBSTITUTES
- 5.1.5 THREAT FROM NEW ENTRANTS
5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 R&D TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 R&D TRENDS IN GLOBAL BIOTECH INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
- 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM
5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER
  - 5.5.1.1 Average selling price trend of platforms, by key player
  - 5.5.1.2 Average selling price trend of consumables, by key player
- 5.5.2 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER
- 5.5.3 AVERAGE SELLING PRICE TREND, BY REGION
5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO (HS CODE 382200)
- 5.6.2 EXPORT SCENARIO (HS CODE 382200)
- 5.6.3 IMPORT SCENARIO (HS CODE 902700)
- 5.6.4 EXPORT SCENARIO (HS CODE 902700)
5.7 KEY CONFERENCES & EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
- 5.10.1 COMPREHENSIVE GENOMIC PROFILING TEST EXPANDS PRECISION ONCOLOGY APPLICATIONS
- 5.10.2 ULTRA-SENSITIVE NGS PANEL ENABLES MEASURABLE RESIDUAL DISEASE MONITORING
- 5.10.3 NGS-BASED MYELOID FUSION PANEL ENHANCES HEMATOLOGIC MALIGNANCY RESEARCH
5.11 IMPACT OF 2025 US TARIFF ON NEXT-GENERATION SEQUENCING MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRY/REGION
  - 5.11.4.1 US
  - 5.11.4.2 Europe
  - 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
  - 5.11.5.1 Pharmaceutical & biotechnology companies
  - 5.11.5.2 CROs and academic & research institutes
  - 5.11.5.3 Hospitals, diagnostic laboratories, and clinics

6 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR

6.1 DECISION-MAKING PROCESS
6.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 6.2.2 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER
6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
6.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
  - 7.1.2.1 North America
  - 7.1.2.2 Europe
  - 7.1.2.3 Asia Pacific
  - 7.1.2.4 Rest of the world
7.2 SUSTAINABILITY INITIATIVES
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

8.1 TECHNOLOGY ANALYSIS
- 8.1.1 KEY TECHNOLOGIES
  - 8.1.1.1 Sequencing by synthesis
  - 8.1.1.2 Ion semiconductor sequencing
  - 8.1.1.3 Nanopore sequencing
  - 8.1.1.4 Single-molecule real-time sequencing (SMRT)
- 8.1.2 COMPLEMENTARY TECHNOLOGIES
  - 8.1.2.1 Automated sample preparation systems
  - 8.1.2.2 Bioinformatics and data analysis platforms
  - 8.1.2.3 CRISPR-based targeted sequencing
  - 8.1.2.4 Multiplex PCR
- 8.1.3 ADJACENT TECHNOLOGIES
  - 8.1.3.1 Single-cell sequencing technology
  - 8.1.3.2 Multiomics integration
  - 8.1.3.3 Spatial genomics and transcriptomics
  - 8.1.3.4 Gene editing technologies
8.2 TECHNOLOGY ROADMAP
8.3 PATENT ANALYSIS
- 8.3.1 METHODOLOGY
- 8.3.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
- 8.3.3 LIST OF KEY PATENTS
8.4 FUTURE APPLICATIONS
8.5 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
- 8.5.1 TOP USE CASES AND MARKET POTENTIAL
- 8.5.2 BEST PRACTICES IN AI-ENABLED NGS WORKFLOWS
- 8.5.3 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET
- 8.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 8.5.5 CLIENTS' READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET

9 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING

9.1 INTRODUCTION
9.2 PRODUCTS
- 9.2.1 DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
9.3 SERVICES
- 9.3.1 SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET

10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE

10.1 INTRODUCTION
10.2 CONSUMABLES
- 10.2.1 LIBRARY PREPARATION KITS & REAGENTS
  - 10.2.1.1 Strong demand and growing applications to ensure market growth
- 10.2.2 SEQUENCING KITS & REAGENTS
  - 10.2.2.1 Focus on technological advancements to support market growth
- 10.2.3 OTHER CONSUMABLES
10.3 PLATFORMS
- 10.3.1 SEQUENCING PLATFORMS
  - 10.3.1.1 Need for advanced technologies to decode genetic information to drive market
  - 10.3.1.2 Illumina
    - 10.3.1.2.1 NovaSeq Series (X/X Plus)
      - 10.3.1.2.1.1 Next-generation ultra-high throughput sequencing to enable large-scale genomics
    - 10.3.1.2.2 MiSeq/MiSeq i100
      - 10.3.1.2.2.1 Compact sequencing platforms to enable rapid and targeted genomic analysis
    - 10.3.1.2.3 NextSeq 1k/2K and 550
      - 10.3.1.2.3.1 Mid-throughput sequencing systems to support diverse research and clinical applications
    - 10.3.1.2.4 NovaSeq 6000
      - 10.3.1.2.4.1 High-throughput sequencing platform to enable large-scale genomic studies
  - 10.3.1.3 Thermo Fisher Scientific
  - 10.3.1.4 PacBio
    - 10.3.1.4.1 Revio
      - 10.3.1.4.1.1 High-throughput long-read sequencing to support market growth
    - 10.3.1.4.2 Sequel II/IIe
      - 10.3.1.4.2.1 High-accuracy, long-read sequencing to support market growth
    - 10.3.1.4.3 Vega Seq
      - 10.3.1.4.3.1 Benchtop long-read sequencing platform to support market growth
  - 10.3.1.5 Oxford Nanopore Technologies
  - 10.3.1.6 Other sequencing platforms
- 10.3.2 LIBRARY PREPARATION PLATFORMS
  - 10.3.2.1 Rising demand for sequencing in clinical applications to drive market
10.4 BIOINFORMATICS TOOLS
- 10.4.1 DATA ANALYSIS SOFTWARE & WORKBENCHES
  - 10.4.1.1 Demand for genome analysis in clinical diagnostics to support market growth
- 10.4.2 DATA VISUALIZATION TOOLS
  - 10.4.2.1 Rising demand for sequencing-based research to support market growth
- 10.4.3 OTHER BIOINFORMATICS TOOLS

11 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY

11.1 INTRODUCTION
11.2 SEQUENCING BY SYNTHESIS
- 11.2.1 HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION
11.3 ION SEMICONDUCTOR SEQUENCING
- 11.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
11.4 SMRT SEQUENCING
- 11.4.1 FOCUS ON RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET
11.5 NANOPORE SEQUENCING
- 11.5.1 EMPHASIS ON DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND
11.6 OTHER SEQUENCING TECHNOLOGIES

12 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW

12.1 INTRODUCTION
12.2 SEQUENCING
- 12.2.1 ABILITY TO ADDRESS COMPLEX GENOMIC REGIONS AND RESOLVE STRUCTURAL VARIATIONS TO DRIVE MARKET
12.3 PRESEQUENCING
- 12.3.1 INCREASED RESEARCH AND SUPPLY AGREEMENTS BETWEEN INDUSTRY PARTICIPANTS TO DRIVE MARKET
12.4 DATA ANALYSIS
- 12.4.1 RISE OF IN-HOUSE INSTALLATION OF BIOINFORMATICS INFRASTRUCTURE TO DRIVE MARKET

13 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER

13.1 INTRODUCTION
13.2 ACADEMIC & RESEARCH INSTITUTES
- 13.2.1 RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.3.1 RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET
13.4 CLINICAL & DIAGNOSTIC LABORATORIES
- 13.4.1 INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
13.5 OTHER END USERS

14 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE

14.1 INTRODUCTION
14.2 SEQUENCING SERVICES
- 14.2.1 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS
  - 14.2.1.1 Advancements in target enrichment technologies to drive market
- 14.2.2 RNA SEQUENCING SERVICES
  - 14.2.2.1 Launch of RNA services and availability of diverse RNA bioinformatics tools to drive market
- 14.2.3 DE NOVO SEQUENCING SERVICES
  - 14.2.3.1 Need for more accurate and faster characterization than traditional methods to drive market
- 14.2.4 CHIP SEQUENCING SERVICES
  - 14.2.4.1 Surge in demand from academic and research institutes to drive market
- 14.2.5 WHOLE-GENOME SEQUENCING SERVICES
  - 14.2.5.1 Technological advancements in next-generation sequencing products to drive market
- 14.2.6 METHYL SEQUENCING SERVICES
  - 14.2.6.1 Large-scale adoption in cancer research to drive market
- 14.2.7 OTHER SEQUENCING SERVICES
14.3 PRESEQUENCING SERVICES
- 14.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES
  - 14.3.1.1 Development of advanced library preparation solutions to drive market
- 14.3.2 SAMPLE PREPARATION SERVICES
  - 14.3.2.1 Applicability in oncology, infectious diseases, metagenomics, and epigenetics to drive market
- 14.3.3 QUALITY CONTROL SERVICES
  - 14.3.3.1 Growing research activities using next-generation sequencing technology to drive market
14.4 BIOINFORMATICS & DATA ANALYSIS SERVICES
- 14.4.1 DATA ANALYSIS SERVICES
  - 14.4.1.1 Increasing demand for precision and speed in genomics for clinical diagnosis to drive market
- 14.4.2 DATA VISUALIZATION & INTERPRETATION SERVICES
  - 14.4.2.1 Rising demand for sequencing-based research to drive market
- 14.4.3 DATA STORAGE & MANAGEMENT SERVICES
  - 14.4.3.1 Need for effective data management to drive market
14.5 NGS PLATFORM SERVICES
- 14.5.1 COMPLIANCE WITH STRINGENT QUALITY AND OPERATIONAL REQUIREMENTS TO DRIVE MARKET

15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW

15.1 INTRODUCTION
15.2 SEQUENCING
- 15.2.1 RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
15.3 PRESEQUENCING SERVICES
- 15.3.1 CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH
15.4 DATA ANALYSIS SERVICES
- 15.4.1 RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET

16 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER

16.1 INTRODUCTION
16.2 ACADEMIC & RESEARCH INSTITUTES
- 16.2.1 GROWING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH
16.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 16.3.1 RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH
16.4 HOSPITALS & CLINICAL LABORATORIES
- 16.4.1 INCREASED APPLICATION IN NGS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE GROWTH
16.5 OTHER END USERS

17 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

17.1 INTRODUCTION
17.2 DIAGNOSTICS
- 17.2.1 CANCER DIAGNOSTICS
  - 17.2.1.1 Rising demand for targeted therapies to drive market
- 17.2.2 INFECTIOUS DISEASE DIAGNOSTICS
  - 17.2.2.1 Rising demand for comprehensive genomic data in clinical diagnostics to propel growth
- 17.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
  - 17.2.3.1 Focus on genetic disease diagnostics to drive growth
- 17.2.4 OTHER DIAGNOSTIC APPLICATIONS
17.3 DRUG DISCOVERY & DEVELOPMENT
- 17.3.1 PHARMACOGENOMICS
  - 17.3.1.1 Rising use of NGS for understanding genomic variants in humans to drive growth
- 17.3.2 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS
17.4 AGRICULTURE & ANIMAL RESEARCH
- 17.4.1 EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS
17.5 OTHER APPLICATIONS

18 NEXT-GENERATION SEQUENCING MARKET, BY REGION

18.1 INTRODUCTION
18.2 NORTH AMERICA
- 18.2.1 US
  - 18.2.1.1 Rapid growth and advancements to lead market
- 18.2.2 CANADA
  - 18.2.2.1 Increasing government initiatives in sequencing research to boost market growth
18.3 EUROPE
- 18.3.1 GERMANY
  - 18.3.1.1 Adoption of advanced sequencing technologies to drive market
- 18.3.2 UK
  - 18.3.2.1 Strategic initiatives and funding for genomics research to support market growth
- 18.3.3 FRANCE
  - 18.3.3.1 Increasing government investment in genomics research to drive growth
- 18.3.4 ITALY
  - 18.3.4.1 Favorable funding scenario to drive adoption of advanced sequencing technology
- 18.3.5 SPAIN
  - 18.3.5.1 Growing focus on advancements in personalized medicine to support market growth
- 18.3.6 NETHERLANDS
  - 18.3.6.1 Well-established research infrastructure to sustain demand for NGS
- 18.3.7 REST OF EUROPE
18.4 ASIA PACIFIC
- 18.4.1 CHINA
  - 18.4.1.1 Favorable regulatory reforms to drive market
- 18.4.2 JAPAN
  - 18.4.2.1 Rising number of collaborations in NGS to drive market
- 18.4.3 INDIA
  - 18.4.3.1 Government and private initiatives for genomics projects to propel market
- 18.4.4 AUSTRALIA
  - 18.4.4.1 Increased genetic research in Australia to support market growth
- 18.4.5 SOUTH KOREA
  - 18.4.5.1 Demand for advanced sequencing technologies to support market
- 18.4.6 REST OF ASIA PACIFIC
18.5 LATIN AMERICA
- 18.5.1 BRAZIL
  - 18.5.1.1 Increased government investments in genomics advancements to drive market
- 18.5.2 MEXICO
  - 18.5.2.1 Rising demand for chronic disease treatment to support growth
- 18.5.3 REST OF LATIN AMERICA
18.6 MIDDLE EAST
- 18.6.1 GCC COUNTRIES
  - 18.6.1.1 Saudi Arabia
    - 18.6.1.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth
  - 18.6.1.2 UAE
    - 18.6.1.2.1 Collaborations to advance genome sequencing and market growth
  - 18.6.1.3 Rest of GCC countries
- 18.6.2 REST OF MIDDLE EAST
18.7 AFRICA
- 18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET

19 COMPETITIVE LANDSCAPE

19.1 INTRODUCTION
19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET
19.3 REVENUE ANALYSIS, 2021-2025
19.4 MARKET SHARE ANALYSIS, 2025
19.5 BRAND/PRODUCT COMPARISON
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 19.6.1 STARS
- 19.6.2 EMERGING LEADERS
- 19.6.3 PERVASIVE PLAYERS
- 19.6.4 PARTICIPANTS
- 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 19.6.5.1 Company footprint
  - 19.6.5.2 Region footprint
  - 19.6.5.3 Offering footprint
  - 19.6.5.4 Application footprint
  - 19.6.5.5 Technology footprint
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 19.7.1 PROGRESSIVE COMPANIES
- 19.7.2 RESPONSIVE COMPANIES
- 19.7.3 DYNAMIC COMPANIES
- 19.7.4 STARTING BLOCKS
- 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  - 19.7.5.1 Detailed list of key startups/SMEs
  - 19.7.5.2 Competitive benchmarking of startups/SMEs
19.8 COMPANY VALUATION & FINANCIAL METRICS
- 19.8.1 COMPANY VALUATION
- 19.8.2 FINANCIAL METRICS
19.9 COMPETITIVE SCENARIO
- 19.9.1 PRODUCT LAUNCHES
- 19.9.2 DEALS
- 19.9.3 EXPANSIONS

20 COMPANY PROFILES

20.1 KEY PLAYERS
- 20.1.1 ILLUMINA, INC.
  - 20.1.1.1 Business overview
  - 20.1.1.2 Products/Services offered
  - 20.1.1.3 Recent developments
    - 20.1.1.3.1 Product launches
    - 20.1.1.3.2 Deals
  - 20.1.1.4 MnM view
    - 20.1.1.4.1 Key strengths
    - 20.1.1.4.2 Strategic choices
    - 20.1.1.4.3 Weaknesses and competitive threats
- 20.1.2 THERMO FISHER SCIENTIFIC INC.
  - 20.1.2.1 Business overview
  - 20.1.2.2 Products/Services offered
  - 20.1.2.3 Recent developments
    - 20.1.2.3.1 Product launches
    - 20.1.2.3.2 Deals
    - 20.1.2.3.3 Expansions
  - 20.1.2.4 MnM view
    - 20.1.2.4.1 Key strengths
    - 20.1.2.4.2 Strategic choices
    - 20.1.2.4.3 Weaknesses and competitive threats
- 20.1.3 AGILENT TECHNOLOGIES, INC.
  - 20.1.3.1 Business overview
  - 20.1.3.2 Products/Services offered
  - 20.1.3.3 Recent developments
    - 20.1.3.3.1 Deals
    - 20.1.3.3.2 Expansions
  - 20.1.3.4 MnM view
    - 20.1.3.4.1 Key strengths
    - 20.1.3.4.2 Strategic choices
    - 20.1.3.4.3 Weaknesses and competitive threats
- 20.1.4 F. HOFFMANN-LA ROCHE LTD.
  - 20.1.4.1 Business overview
  - 20.1.4.2 Products/Services offered
  - 20.1.4.3 Recent developments
    - 20.1.4.3.1 Product launches
    - 20.1.4.3.2 Deals
    - 20.1.4.3.3 Other developments
  - 20.1.4.4 MnM view
    - 20.1.4.4.1 Key strengths
    - 20.1.4.4.2 Strategic choices
    - 20.1.4.4.3 Weaknesses and competitive threats
- 20.1.5 QIAGEN
  - 20.1.5.1 Business overview
  - 20.1.5.2 Products/services offered
  - 20.1.5.3 Recent developments
    - 20.1.5.3.1 Deals
    - 20.1.5.3.2 Expansions
  - 20.1.5.4 MnM view
    - 20.1.5.4.1 Key strengths
    - 20.1.5.4.2 Strategic choices
    - 20.1.5.4.3 Weaknesses and competitive threats
- 20.1.6 DANAHER CORPORATION
  - 20.1.6.1 Business overview
  - 20.1.6.2 Products/services offered
  - 20.1.6.3 Recent developments
    - 20.1.6.3.1 Product launches
    - 20.1.6.3.2 Deals
    - 20.1.6.3.3 Expansions
- 20.1.7 REVVITY
  - 20.1.7.1 Business overview
  - 20.1.7.2 Products/Services offered
  - 20.1.7.3 Recent developments
    - 20.1.7.3.1 Product launches
    - 20.1.7.3.2 Deals
    - 20.1.7.3.3 Expansions
- 20.1.8 EUROFINS SCIENTIFIC
  - 20.1.8.1 Business overview
  - 20.1.8.2 Products/services offered
  - 20.1.8.3 Recent developments
    - 20.1.8.3.1 Deals
- 20.1.9 PACBIO
  - 20.1.9.1 Business overview
  - 20.1.9.2 Products/Services offered
  - 20.1.9.3 Recent developments
    - 20.1.9.3.1 Product launches
    - 20.1.9.3.2 Deals
    - 20.1.9.3.3 Expansions
- 20.1.10 OXFORD NANOPORE TECHNOLOGIES PLC
  - 20.1.10.1 Business overview
  - 20.1.10.2 Products/Services offered
  - 20.1.10.3 Recent developments
    - 20.1.10.3.1 Deals
    - 20.1.10.3.2 Expansions
- 20.1.11 TAKARA BIO INC.
  - 20.1.11.1 Business overview
  - 20.1.11.2 Products/Services offered
  - 20.1.11.3 Recent developments
    - 20.1.11.3.1 Deals
- 20.1.12 BGI GROUP
  - 20.1.12.1 Business overview
  - 20.1.12.2 Products/Services offered
- 20.1.13 BD
  - 20.1.13.1 Business overview
  - 20.1.13.2 Products/Services offered
  - 20.1.13.3 Recent developments
    - 20.1.13.3.1 Product launches
- 20.1.14 10X GENOMICS
  - 20.1.14.1 Business overview
  - 20.1.14.2 Products/Services offered
- 20.1.15 PROMEGA CORPORATION
  - 20.1.15.1 Business overview
  - 20.1.15.2 Products/Services offered
- 20.1.16 LGC LIMITED
  - 20.1.16.1 Business overview
  - 20.1.16.2 Products/Services offered
  - 20.1.16.3 Recent developments
    - 20.1.16.3.1 Deals
- 20.1.17 WUXI BIOLOGICS
  - 20.1.17.1 Business overview
  - 20.1.17.2 Products/Services offered
- 20.1.18 TECAN TRADING AG
  - 20.1.18.1 Business overview
  - 20.1.18.2 Products/Services offered
  - 20.1.18.3 Recent developments
    - 20.1.18.3.1 Deals
- 20.1.19 TWIST BIOSCIENCE
  - 20.1.19.1 Business overview
  - 20.1.19.2 Products/Services offered
  - 20.1.19.3 Recent developments
    - 20.1.19.3.1 Product launches
    - 20.1.19.3.2 Deals
- 20.1.20 AZENTA US INC.
  - 20.1.20.1 Business overview
  - 20.1.20.2 Products/Services offered
  - 20.1.20.3 Recent developments
    - 20.1.20.3.1 Deals
20.2 OTHER PLAYERS
- 20.2.1 MGI TECH CO. LTD.
- 20.2.2 NOVOGENE CO., LTD.
- 20.2.3 NEW ENGLAND BIOLABS
- 20.2.4 GENSCRIPT
- 20.2.5 PSOMAGEN
- 20.2.6 ZYMO RESEARCH CORPORATION
- 20.2.7 HAMILTON COMPANY
- 20.2.8 NEOGENOMICS LABORATORIES
- 20.2.9 FULGENT GENETICS
- 20.2.10 SD BIOSENSOR, INC.

21 RESEARCH METHODOLOGY

21.1 RESEARCH DATA
- 21.1.1 SECONDARY DATA
  - 21.1.1.1 Key data from secondary sources
- 21.1.2 PRIMARY DATA
  - 21.1.2.1 Key data from primary sources
  - 21.1.2.2 Key primary participants
  - 21.1.2.3 Breakdown of primary interviews
  - 21.1.2.4 Key industry insights
21.2 MARKET SIZE ESTIMATION
- 21.2.1 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025
- 21.2.2 SEGMENTAL MARKET SIZE ESTIMATION
21.3 MARKET GROWTH RATE PROJECTIONS
21.4 DATA TRIANGULATION
21.5 FACTOR ANALYSIS
21.6 RESEARCH ASSUMPTIONS
21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT

22 APPENDIX

22.1 DISCUSSION GUIDE
22.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
22.3 CUSTOMIZATION OPTIONS
22.4 RELATED REPORTS
22.5 AUTHOR DETAILS

Product Code: BT 2697

List of Tables

TABLE 1 NEXT-GENERATION SEQUENCING MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT OF MARKET DYNAMICS
TABLE 3 NEXT-GENERATION SEQUENCING MARKET: PORTER'S FIVE FORCES
TABLE 4 NEXT-GENERATION SEQUENCING MARKET: ROLE OF PLAYERS IN ECOSYSTEM
TABLE 5 AVERAGE SELLING PRICE TREND OF PLATFORMS, BY KEY PLAYER, 2023-2025 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2023-2025 (USD)
TABLE 7 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD)
TABLE 8 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2025 (USD)
TABLE 9 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 10 IMPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (TONS)
TABLE 11 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 12 EXPORT DATA FOR HS CODE 382200-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (TONS)
TABLE 13 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 14 IMPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (TONS)
TABLE 15 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD THOUSAND)
TABLE 16 EXPORT DATA FOR HS CODE 902700-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (TONS)
TABLE 17 NEXT-GENERATION SEQUENCING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026-MARCH 2027
TABLE 18 RECIPROCAL TARIFF RATES ADJUSTED BY US
TABLE 19 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES
TABLE 20 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE
TABLE 21 KEY BUYING CRITERIA FOR PRODUCTS, BY END USER
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015-2025
TABLE 27 KEY PATENTS, 2023-2025
TABLE 28 CASE STUDIES OF AI IMPLEMENTATION IN NEXT-GENERATION SEQUENCING MARKET
TABLE 29 CLIENT'S READINESS TO ADOPT AI-INTEGRATED SEQUENCING SOLUTIONS IN NEXT-GENERATION SEQUENCING MARKET
TABLE 30 NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 31 NGS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 32 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 33 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 34 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 35 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 36 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 38 NGS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 40 EUROPE: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 41 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 42 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 43 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 45 NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 46 NGS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 47 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 48 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 49 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 50 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 51 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 53 NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 54 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 56 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 57 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 58 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 59 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION/REGION, 2024-2031 (USD MILLION)
TABLE 60 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 61 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 63 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 64 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 65 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 66 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 67 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 68 OTHER CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 69 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 70 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 71 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 72 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 73 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 75 NGS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 77 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 78 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 79 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 80 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 82 NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 83 SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 85 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 86 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 87 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 88 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 90 SEQUENCING PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 91 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 92 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 93 NOVASEQ (X/X PLUS) SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 94 MISEQ/MISEQ I100 SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 NEXTSEQ 1K/2K AND 550 SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 96 NOVASEQ 6000 SYSTEMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 97 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 98 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 100 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 101 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 102 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 103 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 104 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 105 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION/REGION, 2024-2031 (USD MILLION)
TABLE 106 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 107 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 108 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 109 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 110 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 111 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 112 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 113 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 114 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 115 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 117 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 118 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 119 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 120 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 121 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 122 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 123 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 124 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 125 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 126 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 127 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 128 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 129 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 130 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 131 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 132 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 133 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 134 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 135 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 136 NGS TECHNOLOGIES, BY COMPANY
TABLE 137 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 138 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 139 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 140 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 141 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 142 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 143 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 144 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 145 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 146 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 147 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 148 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 149 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 150 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 151 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 152 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 153 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 154 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 156 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 157 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 158 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 159 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 160 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 161 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 162 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 163 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 164 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 165 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 166 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 167 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 168 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 169 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 170 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 171 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 172 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 173 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 174 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 175 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 176 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 177 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 178 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 179 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 180 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 181 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 182 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 183 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 184 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 185 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 186 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 187 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 188 NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 189 NORTH AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 190 EUROPE: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 191 ASIA PACIFIC: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 192 LATIN AMERICA: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 193 MIDDLE EAST: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2024-2031 (USD MILLION)
TABLE 194 GCC COUNTRIES: NEXT-GENERATION SEQUENCING PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 195 NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 196 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 197 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 198 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 199 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 200 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 201 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 202 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 203 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 204 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 205 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 206 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 207 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 208 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 209 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 210 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 211 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 212 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 214 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 215 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 216 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 217 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 218 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 219 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 221 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 222 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 223 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 224 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 226 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 227 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 228 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 229 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 230 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 231 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 232 SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 234 NORTH AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 235 EUROPE: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 236 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 237 LATIN AMERICA: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 238 MIDDLE EAST: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 239 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING SERVICES AND CUSTOM PANELS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 240 RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 241 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 242 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 244 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 245 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 246 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 247 DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 248 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 249 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 250 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 251 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 252 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 253 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 254 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 255 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 256 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 257 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 258 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 259 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 260 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 261 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 262 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 263 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 264 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 265 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 266 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 267 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 268 METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 269 NORTH AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 270 EUROPE: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 271 ASIA PACIFIC: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 272 LATIN AMERICA: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 273 MIDDLE EAST: METHYL SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 274 GCC COUNTRIES: METHYL SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 275 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 276 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 277 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 278 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 279 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 280 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 281 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 282 PRESEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 283 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 284 EUROPE: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 285 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 286 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 287 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 288 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 289 PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 291 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 292 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 293 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 294 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 295 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 296 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 297 SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 298 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 299 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 300 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 301 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 302 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 303 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 304 QUALITY CONTROL SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 305 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 306 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 307 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 308 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 309 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 310 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 311 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 312 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 313 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 314 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 315 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 316 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 317 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 318 BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 319 DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 320 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 321 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 322 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 323 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 324 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 325 GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 326 DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 327 NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 328 EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 329 ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 330 LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 331 MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 332 GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 333 DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 334 NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 335 EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 336 ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 337 LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 338 MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 339 GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 340 NGS PLATFORM SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 341 NORTH AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 342 EUROPE: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 343 ASIA PACIFIC: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 344 LATIN AMERICA: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 345 MIDDLE EAST: NGS PLATFORM SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 346 GCC COUNTRIES: NGS PLATFORM SERVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 347 NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 348 NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 349 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 350 EUROPE: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 351 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 352 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 353 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 354 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 355 NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 356 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 357 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 358 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 359 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 360 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING, BY REGION, 2024-2031 (USD MILLION)
TABLE 361 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 362 NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 363 NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 364 EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 365 ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 366 LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 367 MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2024-2031 (USD MILLION)
TABLE 368 GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 369 NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 370 NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 371 NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 372 EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 373 ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 374 LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 375 MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
TABLE 376 GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 377 NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 378 NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 379 EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 380 ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 381 LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 382 MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 383 GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 384 NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 385 NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 386 EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 387 ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 388 LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 389 MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 390 GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY/REGION 2024-2031 (USD MILLION)
TABLE 391 NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 392 NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 393 EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 394 ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 395 LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 396 MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 397 GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 398 NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 399 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 400 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 401 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 402 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 403 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 404 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 405 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 406 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)
TABLE 408 CANCER DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 409 NORTH AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 410 EUROPE: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 411 ASIA PACIFIC: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 412 LATIN AMERICA: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 413 MIDDLE EAST: CANCER DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 414 GCC COUNTRIES: CANCER DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 415 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 416 NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 417 EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 418 ASIA PACIFIC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 419 LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 420 MIDDLE EAST: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 421 GCC COUNTRIES: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 422 REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 423 NORTH AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 424 EUROPE: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 425 ASIA PACIFIC: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 426 LATIN AMERICA: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 427 MIDDLE EAST: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 428 GCC COUNTRIES: REPRODUCTIVE HEALTH DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 429 OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 430 NORTH AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 431 EUROPE: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 432 ASIA PACIFIC: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 433 LATIN AMERICA: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 434 MIDDLE EAST: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 435 GCC COUNTRIES: OTHER DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 436 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 437 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 438 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 439 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 440 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 441 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 442 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 443 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 444 PHARMACOGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 445 NORTH AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 446 EUROPE: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 447 ASIA PACIFIC: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 448 LATIN AMERICA: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 449 MIDDLE EAST: PHARMACOGENOMICS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 450 GCC COUNTRIES: PHARMACOGENOMICS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 451 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 452 NORTH AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 453 EUROPE: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 454 ASIA PACIFIC: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 455 LATIN AMERICA: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 456 MIDDLE EAST: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 457 GCC COUNTRIES: OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 458 AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 459 NORTH AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 460 EUROPE: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 461 ASIA PACIFIC: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 462 LATIN AMERICA: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 463 MIDDLE EAST: AGRICULTURE & ANIMAL RESEARCH MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 464 GCC COUNTRIES: AGRICULTURE & ANIMAL RESEARCH MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 465 OTHER APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 466 NORTH AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 467 EUROPE: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 468 ASIA PACIFIC: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 469 LATIN AMERICA: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 470 MIDDLE EAST: OTHER APPLICATIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 471 GCC COUNTRIES: OTHER APPLICATIONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 472 NGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 473 NORTH AMERICA: NGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 474 NORTH AMERICA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 475 NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 476 NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 477 NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 478 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 479 NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 480 NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 481 NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 482 NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 483 NORTH AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 484 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 485 NORTH AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 486 NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 487 NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 488 NORTH AMERICA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 489 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 490 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 491 US: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 492 US: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 493 US: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 494 US: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 495 US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 496 US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 497 US: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 498 US: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 499 US: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 500 US: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 501 US: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 502 US: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 503 US: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 504 US: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 505 US: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 506 US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 507 US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 508 CANADA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 509 CANADA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 510 CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 511 CANADA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 512 CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 513 CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 514 CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 515 CANADA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 516 CANADA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 517 CANADA: PRESEQUENCING SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 518 CANADA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 519 CANADA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 520 CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 521 CANADA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 522 CANADA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 523 CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 524 CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 525 EUROPE: NGS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 526 EUROPE: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 527 EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 528 EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 529 EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 530 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 531 EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 532 EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 533 EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 534 EUROPE: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 535 EUROPE: PRESEQUENCING SERVICES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 536 EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 537 EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 538 EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 539 EUROPE: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 540 EUROPE: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 541 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 542 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 543 GERMANY: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 544 GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 545 GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 546 GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 547 GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 548 GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 549 GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 550 GERMANY: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 551 GERMANY: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 552 GERMANY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 553 GERMANY: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 554 GERMANY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 555 GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 556 GERMANY: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 557 GERMANY: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 558 GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 559 GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 560 UK: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 561 UK: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 562 UK: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 563 UK: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 564 UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 565 UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 566 UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 567 UK: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 568 UK: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 569 UK: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 570 UK: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 571 UK: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 572 UK: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 573 UK: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 574 UK: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 575 UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 576 UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 577 FRANCE: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 578 FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 579 FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 580 FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 581 FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 582 FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 583 FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 584 FRANCE: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 585 FRANCE: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 586 FRANCE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 587 FRANCE: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 588 FRANCE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 589 FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 590 FRANCE: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 591 FRANCE: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 592 FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 593 FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 594 ITALY: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 595 ITALY: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 596 ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 597 ITALY: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 598 ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 599 ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 600 ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 601 ITALY: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 602 ITALY: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 603 ITALY: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 604 ITALY: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 605 ITALY: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 606 ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 607 ITALY: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 608 ITALY: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 609 ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 610 ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 611 SPAIN: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 612 SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 613 SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 614 SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 615 SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 616 SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 617 SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 618 SPAIN: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 619 SPAIN: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 620 SPAIN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 621 SPAIN: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 622 SPAIN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 623 SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 624 SPAIN: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 625 SPAIN: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 626 SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 627 SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 628 NETHERLANDS: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 629 NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 630 NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 631 NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 632 NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 633 NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 634 NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 635 NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 636 NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 637 NETHERLANDS: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 638 NETHERLANDS: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 639 NETHERLANDS: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 640 NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 641 NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 642 NETHERLANDS: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 643 NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 644 NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 645 REST OF EUROPE: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 646 REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 647 REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 648 REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 649 REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 650 REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 651 REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 652 REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 653 REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 654 REST OF EUROPE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 655 REST OF EUROPE: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 656 REST OF EUROPE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 657 REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 658 REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 659 REST OF EUROPE: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 660 REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 661 REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 662 ASIA PACIFIC: NGS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 663 ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 664 ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 665 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 666 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 667 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 668 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 669 ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 670 ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 671 ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 672 ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 673 ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 674 ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 675 ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 676 ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 677 ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 678 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 679 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 680 CHINA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 681 CHINA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 682 CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 683 CHINA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 684 CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 685 CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 686 CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 687 CHINA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 688 CHINA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 689 CHINA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 690 CHINA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 691 CHINA: FOR BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 692 CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 693 CHINA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 694 CHINA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 695 CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 696 CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 697 JAPAN: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 698 JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 699 JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 700 JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 701 JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 702 JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 703 JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 704 JAPAN: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 705 JAPAN: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 706 JAPAN: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 707 JAPAN: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 708 JAPAN: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 709 JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 710 JAPAN: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 711 JAPAN: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 712 JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 713 JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 714 INDIA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 715 INDIA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 716 INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 717 INDIA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 718 INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 719 INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 720 INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 721 INDIA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 722 INDIA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 723 INDIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 724 INDIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 725 INDIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 726 INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 727 INDIA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 728 INDIA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 729 INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 730 INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 731 AUSTRALIA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 732 AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 733 AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 734 AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 735 AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 736 AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 737 AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 738 AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 739 AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 740 AUSTRALIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 741 AUSTRALIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 742 AUSTRALIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 743 AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 744 AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 745 AUSTRALIA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 746 AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 747 AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 748 SOUTH KOREA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 749 SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 750 SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 751 SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 752 SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 753 SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 754 SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 755 SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 756 SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 757 SOUTH KOREA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 758 SOUTH KOREA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 759 SOUTH KOREA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 760 SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 761 SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 762 SOUTH KOREA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 763 SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 764 SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 765 REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 766 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 767 REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 768 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 769 REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 770 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 771 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 772 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 773 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 774 REST OF ASIA PACIFIC: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 775 REST OF ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 776 REST OF ASIA PACIFIC: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 777 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 778 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 779 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 780 REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 781 REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 782 LATIN AMERICA: NGS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 783 LATIN AMERICA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 784 LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 785 LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 786 LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 787 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 788 LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 789 LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 790 LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 791 LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 792 LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 793 LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 794 LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 795 LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 796 LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 797 LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 798 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 799 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 800 BRAZIL: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 801 BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 802 BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 803 BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 804 BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 805 BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 806 BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 807 BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 808 BRAZIL: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 809 BRAZIL: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 810 BRAZIL: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 811 BRAZIL: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 812 BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 813 BRAZIL: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 814 BRAZIL: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 815 BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 816 BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 817 MEXICO: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 818 MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 819 MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 820 MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 821 MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 822 MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 823 MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 824 MEXICO: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 825 MEXICO: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 826 MEXICO: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 827 MEXICO: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 828 MEXICO: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 829 MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 830 MEXICO: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 831 MEXICO: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 832 MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 833 MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 834 REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 835 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 836 REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 837 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 838 REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 839 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 840 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 841 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 842 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 843 REST OF LATIN AMERICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 844 REST OF LATIN AMERICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 845 REST OF LATIN AMERICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 846 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 847 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 848 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 849 REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 850 REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 851 MIDDLE EAST: NGS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 852 MIDDLE EAST: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 853 MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 854 MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 855 MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 856 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 857 MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 858 MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 859 MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 860 MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 861 MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 862 MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 863 MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 864 MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 865 MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 866 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 867 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 868 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 869 GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 870 GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 871 GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 872 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 873 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 874 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 875 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 876 GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 877 GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 878 GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 879 GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 880 GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 881 GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 882 GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 883 GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 884 GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 885 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 886 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 887 SAUDI ARABIA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 888 SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 889 SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 890 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 891 SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 892 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 893 SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 894 SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 895 SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 896 SAUDI ARABIA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 897 SAUDI ARABIA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 898 SAUDI ARABIA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 899 SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 900 SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 901 SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 902 SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 903 SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 904 UAE: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 905 UAE: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 906 UAE: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 907 UAE: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 908 UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 909 UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 910 UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 911 UAE: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 912 UAE: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 913 UAE: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 914 UAE: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 915 UAE: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 916 UAE: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 917 UAE: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 918 UAE: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 919 UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 920 UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 921 REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 922 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 923 REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 924 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 925 REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 926 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 927 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 928 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 929 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 930 REST OF GCC COUNTRIES: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 931 REST OF GCC COUNTRIES: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 932 REST OF GCC COUNTRIES: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 933 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 934 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 935 REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 936 REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 937 REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 938 REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 939 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 940 REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 941 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 942 REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 943 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 944 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 945 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 946 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 947 REST OF MIDDLE EAST: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 948 REST OF MIDDLE EAST: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 949 REST OF MIDDLE EAST: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 950 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 951 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 952 REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 953 REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 954 REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 955 AFRICA: NGS MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 956 AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 957 AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 958 AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 959 AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 960 AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2024-2031 (USD MILLION)
TABLE 961 AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 962 AFRICA: NGS PRODUCTS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 963 AFRICA: NGS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 964 AFRICA: PRESEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 965 AFRICA: SEQUENCING SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 966 AFRICA: BIOINFORMATICS & DATA ANALYSIS SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 967 AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2024-2031 (USD MILLION)
TABLE 968 AFRICA: NGS SERVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 969 AFRICA: NGS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 970 AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 971 AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 972 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, JANUARY 2023-JANUARY 2026
TABLE 973 NGS MARKET: DEGREE OF COMPETITION
TABLE 974 NGS MARKET: REGION FOOTPRINT
TABLE 975 NGS MARKET: OFFERING FOOTPRINT
TABLE 976 NGS MARKET: APPLICATION FOOTPRINT
TABLE 977 NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT
TABLE 978 NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 979 NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 980 NGS MARKET: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 981 NGS MARKET: DEALS, JANUARY 2023-JANUARY 2026
TABLE 982 NGS MARKET: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 983 ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 984 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 985 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 986 ILLUMINA, INC.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 987 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 988 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 989 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 990 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 991 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 992 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 993 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 994 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 995 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 996 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 997 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 998 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 999 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1000 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1001 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023-JANUARY 2026
TABLE 1002 QIAGEN: COMPANY OVERVIEW
TABLE 1003 QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 1004 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1005 QIAGEN: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1006 QIAGEN: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 1007 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 1008 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1009 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1010 DANAHER CORPORATION: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1011 DANAHER CORPORATION: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 1012 REVVITY: COMPANY OVERVIEW
TABLE 1013 REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 1014 REVVITY: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1015 REVVITY: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1016 REVVITY: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 1017 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 1018 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 1019 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1020 PACBIO: COMPANY OVERVIEW
TABLE 1021 PACBIO: PRODUCTS/SERVICES OFFERED
TABLE 1022 PACBIO: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1023 PACBIO: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1024 PACBIO: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 1025 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
TABLE 1026 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED
TABLE 1027 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1028 OXFORD NANOPORE TECHNOLOGIES PLC: EXPANSIONS, JANUARY 2023-JANUARY 2026
TABLE 1029 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 1030 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
TABLE 1031 TAKARA BIO INC.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1032 BGI GROUP: COMPANY OVERVIEW
TABLE 1033 BGI GROUP: PRODUCTS/SERVICES OFFERED
TABLE 1034 BD: COMPANY OVERVIEW
TABLE 1035 BD: PRODUCTS/SERVICES OFFERED
TABLE 1036 BD: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1037 10X GENOMICS: COMPANY OVERVIEW
TABLE 1038 10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 1039 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 1040 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1041 LGC LIMITED: COMPANY OVERVIEW
TABLE 1042 LGC LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 1043 LGC LIMITED: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1044 WUXI BIOLOGICS: COMPANY OVERVIEW
TABLE 1045 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
TABLE 1046 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 1047 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
TABLE 1048 TECAN TRADING AG: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1049 TWIST BIOSCIENCE: COMPANY OVERVIEW
TABLE 1050 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
TABLE 1051 TWIST BIOSCIENCE: PRODUCT LAUNCHES, JANUARY 2023-JANUARY 2026
TABLE 1052 TWIST BIOSCIENCE: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1053 AZENTA US INC.: COMPANY OVERVIEW
TABLE 1054 AZENTA US INC.: PRODUCTS/SERVICES OFFERED
TABLE 1055 AZENTA US INC.: DEALS, JANUARY 2023-JANUARY 2026
TABLE 1056 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 1057 RISK ASSESSMENT

List of Figures

FIGURE 1 NEXT-GENERATION SEQUENCING MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2 NEXT-GENERATION SEQUENCING MARKET: YEARS CONSIDERED
FIGURE 3 MARKET SCENARIO
FIGURE 4 GLOBAL NEXT-GENERATION SEQUENCING MARKET, 2024-2031
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NEXT-GENERATION SEQUENCING MARKET
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF NEXT-GENERATION SEQUENCING MARKET
FIGURE 7 HIGH-GROWTH SEGMENTS IN NEXT-GENERATION SEQUENCING MARKET
FIGURE 8 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
FIGURE 9 ADVANCEMENTS IN SEQUENCING PLATFORMS TO DRIVE MARKET GROWTH
FIGURE 10 PRODUCTS OFFERING AND US LED NORTH AMERICA'S NEXT-GENERATION SEQUENCING MARKET IN 2025
FIGURE 11 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD
FIGURE 12 PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 13 NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 NEXT-GENERATION SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 15 GROWTH OF GLOBAL GDP, 2020-2024
FIGURE 16 VALUE CHAIN ANALYSIS
FIGURE 17 NEXT-GENERATION SEQUENCING MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 AVERAGE SELLING PRICE OF PLATFORMS, BY KEY PLAYER, 2025 (USD)
FIGURE 19 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2025 (USD)
FIGURE 20 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2025 (USD)
FIGURE 21 AVERAGE SELLING PRICE, BY REGION, 2025 (USD)
FIGURE 22 NEXT-GENERATION SEQUENCING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 23 INVESTMENT & FUNDING SCENARIO, 2023-2025 (USD MILLION)
FIGURE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
FIGURE 25 KEY BUYING CRITERIA FOR NGS PRODUCTS, BY END USER
FIGURE 26 PATENT APPLICATIONS IN NEXT-GENERATION SEQUENCING MARKET, JANUARY 2015-DECEMBER 2025
FIGURE 27 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
FIGURE 28 NOVASEQ SERIES (X/X PLUS) PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 29 MISEQ/MISEQ I100 PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 30 NEXTSEQ 1K/2K AND 550 PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 31 NOVASEQ 6000 PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 32 REVIO PLATFORM REVENUE, 2023-2025 (USD MILLION)
FIGURE 33 REVIO PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 34 SEQUEL II/IIE PLATFORM REVENUE, 2023-2025 (USD MILLION)
FIGURE 35 SEQUEL II/IIE PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 36 VEGA SEQ PLATFORM REVENUE, 2023-2025 (USD MILLION)
FIGURE 37 VEGA SEQ PLATFORM SHIPMENTS, 2023-2025 (UNITS)
FIGURE 38 NORTH AMERICA: NGS MARKET SNAPSHOT
FIGURE 39 ASIA PACIFIC: NGS MARKET SNAPSHOT
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS, 2021-2025 (USD BILLION)
FIGURE 41 MARKET SHARE ANALYSIS, 2025
FIGURE 42 NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 43 NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 44 NGS MARKET: COMPANY FOOTPRINT
FIGURE 45 NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 46 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 47 EV/EBITDA OF KEY VENDORS
FIGURE 48 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2025)
FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2025)
FIGURE 55 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
FIGURE 56 PACBIO: COMPANY SNAPSHOT (2025)
FIGURE 57 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2024)
FIGURE 58 TAKARA BIO INC.: COMPANY SNAPSHOT (2024)
FIGURE 59 BD: COMPANY SNAPSHOT (2025)
FIGURE 60 10X GENOMICS: COMPANY SNAPSHOT (2025)
FIGURE 61 LGC LIMITED: COMPANY SNAPSHOT (2024)
FIGURE 62 WUXI BIOLOGICS: COMPANY SNAPSHOT (2024)
FIGURE 63 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
FIGURE 64 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2025)
FIGURE 65 AZENTA US INC.: COMPANY SNAPSHOT (2025)
FIGURE 66 NEXT-GENERATION SEQUENCING MARKET: RESEARCH DESIGN
FIGURE 67 NEXT-GENERATION SEQUENCING MARKET: BREAKDOWN OF PRIMARIES
FIGURE 68 NEXT-GENERATION SEQUENCING MARKET: INSIGHTS FROM PRIMARIES
FIGURE 69 GLOBAL NEXT-GENERATION SEQUENCING MARKET ESTIMATION, 2025
FIGURE 70 NEXT-GENERATION SEQUENCING MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH), 2025
FIGURE 71 ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC.: REVENUE ANALYSIS, 2025
FIGURE 72 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 73 NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS
FIGURE 74 NEXT-GENERATION SEQUENCING MARKET: DATA TRIANGULATION

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

List of Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights into the following points:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 CUSTOMER LANDSCAPE & BUYER BEHAVIOUR

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

8 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

9 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING

10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE

11 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY

12 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW

13 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER

14 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE

15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW

16 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER

17 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

18 NEXT-GENERATION SEQUENCING MARKET, BY REGION

19 COMPETITIVE LANDSCAPE

20 COMPANY PROFILES

21 RESEARCH METHODOLOGY

22 APPENDIX

List of Tables

List of Figures